Akanda Corp (AKAN)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.84-1.40%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$404,394

Revenue YoY

-15.2%

Net profit

$-6.2M

Net margin

-1,532.3%

Market cap

$14.0M

Forward P/E

0.0

P/B

2.21

Book value

$-19.37

EPS (TTM)

$-14,935.32

52-week high

$78.90

52-week low

$1.00

50-day MA

$2.50

200-day MA

$8.38

Beta

14.19

Insiders

0.59%

Institutions

0.08%

Fund	Stake
Integrated Wealth Concepts LLC	0.02%
UBS Group AG	0.01%
Wells Fargo & Co	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
SBI Securities Co Ltd	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Akanda Corp — free to start.

Data updated 2026-11-07.